Pacira BioSciences
PCRX
PCRX
231 hedge funds and large institutions have $2.06B invested in Pacira BioSciences in 2019 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 65 increasing their positions, 73 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.6% more ownership
Funds ownership: 108.38% → 108.97% (+0.6%)
11% less repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 73
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
231
Holding in Top 10
4
Calls
$5.71M
Puts
$2.57M
Top Buyers
| 1 | +$34.9M | |
| 2 | +$26.4M | |
| 3 | +$18.1M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$17.2M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$12.5M |
Top Sellers
| 1 | -$60.9M | |
| 2 | -$18M | |
| 3 | -$16M | |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$14.9M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$13.6M |